Nadler Evan P, Reblock Kimberly K, Ford Henri R, Gaines Barbara A
Department of Surgery, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.
Surg Infect (Larchmt). 2003 Winter;4(4):327-33. doi: 10.1089/109629603322761382.
Children with perforated appendicitis often have a prolonged hospital course complicated by surgical site or intra-abdominal infections. Treatment with multiple intravenous (IV) antibiotics after appendectomy has been the standard of care for these patients. We have recently adopted a protocol using piperacillin-tazobactam (PT) as a single agent in lieu of the standard multi-drug regimen (MD). We hypothesized that PT would be as effective as MD in reducing postoperative complications and would result in decreased resource utilization.
We reviewed the medical records of all children admitted to our hospital between January 1, 1998 and December 31, 2001 with the diagnosis of perforated appendicitis. Patients who underwent operation within the first 24 h of admission were divided into two groups based on their antibiotic regimen: PT versus MD. Demographic data, duration of presenting symptoms, initial WBC, length of stay, and infectious complications were abstracted. Categorical data were compared using Chi square analysis; continuous variables were compared using Student's t-test when the data were normally distributed and the Mann-Whitney U test when the data were skewed.
There was no difference between the PT (n = 51) and MD (n = 43) groups with respect to age, duration of presenting symptoms, initial WBC, or length of hospital stay. However, patients in the MD group had a significantly higher overall complication rate than those in the PT group (14/43 vs. 4/51, p = 0.002). Antibiotic-related complications including surgical site infections, venous catheter-related infections, intra-abdominal abscesses, and drug reactions were also higher in the MD group (10/43 vs. 4/51, p = 0.04). The outpatient charges for each patient based on an average of seven days of home antibiotics were $2,460 for the PT group and $4,349 for the MD group.
Children with perforated appendicitis can be managed effectively with a single broad-spectrum antibiotic after appendectomy. Monotherapy is not only more efficacious than multi-drug therapy, but may be more cost effective. The use of monotherapy for children with perforated appendicitis after adequate source control should be considered the treatment of choice.
穿孔性阑尾炎患儿的住院病程往往较长,并伴有手术部位或腹腔内感染等并发症。阑尾切除术后使用多种静脉抗生素治疗一直是这些患者的标准治疗方法。我们最近采用了一种方案,即使用哌拉西林 - 他唑巴坦(PT)作为单一药物来替代标准的多药联合方案(MD)。我们假设PT在降低术后并发症方面与MD一样有效,并且会减少资源利用。
我们回顾了1998年1月1日至2001年12月31日期间我院收治的所有诊断为穿孔性阑尾炎患儿的病历。入院后24小时内接受手术的患者根据抗生素治疗方案分为两组:PT组和MD组。提取人口统计学数据、症状持续时间、初始白细胞计数、住院时间和感染并发症情况。分类数据采用卡方分析进行比较;连续变量在数据呈正态分布时采用学生t检验进行比较,数据呈偏态分布时采用曼 - 惠特尼U检验进行比较。
PT组(n = 51)和MD组(n = 43)在年龄、症状持续时间、初始白细胞计数或住院时间方面没有差异。然而,MD组患者的总体并发症发生率显著高于PT组(14/43对4/51,p = 0.002)。MD组抗生素相关并发症包括手术部位感染、静脉导管相关感染、腹腔内脓肿和药物反应也更高(10/43对4/51,p = 0.04)。基于平均7天家庭抗生素使用情况,PT组每位患者的门诊费用为2460美元,MD组为4349美元。
穿孔性阑尾炎患儿阑尾切除术后使用单一广谱抗生素即可有效治疗。单药治疗不仅比多药治疗更有效,而且可能更具成本效益。在充分控制感染源后,对于穿孔性阑尾炎患儿采用单药治疗应被视为首选治疗方法。